Douglas D. Leipold
Douglas D. Leipold publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and CAR-T cell therapy research.
- World rank
- #564,426 of 7,710,434 ranked researchers
- Rank in China
- #71,256 of 978,568
- Works
- 73
- Citations
- 3.4k
- Citations per work
- 47.2
What does Douglas D. Leipold research?
Douglas D. Leipold's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4561.4%
- Medicine4561.4%
- Everything else1318.3%
- Life Sciences1318.3%
- Physical Sciences12.0%
- Engineering12.0%
- 1Oncology35% of their works
- 2Radiology, Nuclear Medicine and Imaging27% of their works
- 3Molecular Biology11% of their works
- 4Immunology5% of their works
- 5Pharmacology3% of their works
- 6Biomedical Engineering2% of their works
Research topics
Which keywords describe Douglas D. Leipold's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Breast Cancer, HER2, PET Imaging and CAR T Cells.
- PROTACs
- BET Bromodomains
- Biopharmaceuticals
- Radiopharmaceuticals
- Fibroblast Activation Protein
- CAR T Cells
- HER2
- Fc Receptors
- Therapeutic Antibodies
- Monoclonal Antibodies
- Antibody Engineering
- Breast Cancer
- PET Imaging
- Chimeric Antigen Receptor
- Tumor Microenvironment
- Targeted Therapy
- Protein Aggregation
- High-Throughput Analysis
- Protein Microarrays
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Monoclonal Antibodies402 topics
- Therapeutic Antibodies402 topics
- Antibody Engineering361 topic
- Fc Receptors361 topic
- Breast Cancer341 topic
- HER2341 topic
- PET Imaging112 topics
- CAR T Cells81 topic
- Chimeric Antigen Receptor81 topic
- Fibroblast Activation Protein61 topic
- Tumor Microenvironment61 topic
- Radiopharmaceuticals51 topic
- Targeted Therapy51 topic
- Biopharmaceuticals41 topic
- Protein Aggregation41 topic
- BET Bromodomains31 topic
- High-Throughput Analysis31 topic
- PROTACs31 topic
- Protein Microarrays31 topic
Where does Douglas D. Leipold work?
Douglas D. Leipold's main affiliation in the publication record is WuXi AppTec (China), China.
How many publications and citations does Douglas D. Leipold have?
OpenAlex counts 73 works and 3,443 citations for Douglas D. Leipold, an h-index of 24, ranking #564,426 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Douglas D. Leipold. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.